Welcome Bathroom Design and Remodeling Specialists
CUSTOM BATHROOM DESIGN AND REMODELING
Featured News & Promo
There’s no denying that there’s a great deal of development capacity for the cannabis market. Grand View Research study anticipates that the worldwide legal marijuana market will be worth $736 billion by 2027, up from an estimated $18 billion in2019
And while there are significant opportunities for marijuana manufacturers, there’s likewise run the risk of that occurs with that growth. Companies are discovering the hard method that being too aggressive can do more harm than excellent as multiple marijuana producers have been laying off staff and cutting expenses over the previous several months in an effort to make their businesses more sustainable.
The market is still dealing with numerous growing pains ahead, and that’s why purchasing the three stocks below, which have more minimal exposure to the industry, may be a much more secure bet for cannabis financiers today.
Shopify ( NYSE: STORE) is a tech business that uses companies a platform on which to carry out deals and help process their sales. Many cannabis manufacturers in Canada utilize Shopify, and in September, it announced it would be providing its services to U.S. companies that are offering hemp-derived cannabidiol (CBD) products.
With the passing of the farm costs in 2018, the hemp-derived products are now legal federally and provide Shopify a way to use the industry’s development without contravening of federal regulators in the U.S.
Image source: Getty Images.
For cannabis companies that may do not have the technical proficiency to set up and run their own e-commerce sites, Shopify’s easy-to-use platform and user interface can add considerable value– not to point out sales. Even government-run sites, including the Ontario Marijuana Store, have actually opted to use Shopify to process online marijuana sales.
The trust and credibility Shopify has established in its industry makes it an easy option for cannabis companies. Must cannabis legalization progress federally, there’s the capacity for Shopify to ultimately use its services to business offering tetrahydrocannabinol (THC) also.
Although it has the opportunity to gain from the cannabis industry’s development, with more than 1 million merchants using its platform, Shopify isn’t greatly exposed to the industry and uses cannabis financiers a lot of diversity and security.
Shopify’s sales have actually grown from $205 million in 2015 to $1.6 billion this previous year. Regrettably, its net losses worsened from $19 million in 2015 to $125 million in2015 At a market cap of nearly $60 billion, it’s not an inexpensive buy, trading at over 34 times its sales over the past 12 months ( worth stocks generally trade well below 10 times their earnings). But with the explosive growth Shopify’s already accomplished coupled with a fast-growing cannabis market, numerous development investors are more than going to look past its appraisal and delighted to purchase the stock for the substantial upside it still has over the long term.
2. Alimentation Couche-Tard
Alimentation Couche-Tard ( OTC: ANCUF) is another stock that’s dipped its toes into the cannabis industry. The international corner store operator is understood for its Circle K brand name of stores, but in 2015, it chose to gain direct exposure to cannabis by investing in a 9.9%stake of Fire & Flower, a marijuana retailer in Canada with dozens of areas. The business revealed interest in the market in 2018, when pot was first legalized in Canada, with President and CEO Brian Hannasch specifying, “We’re a $60- billion company. If we’re going to divert our focus from our core, we have to believe that it results in a course of some substantial scale.”
Development is certainly something the cannabis industry can offer Couche-Tard, and one of the things the company can provide investors in return is stability.
3. GW Pharmaceuticals
GW Pharmaceuticals( NASDAQ: GWPH) is understood for its cannabis-based medication, Epidiolex, the very first such drug that the Fda (FDA) has approved for usage in the U.S. for 2 unusual types of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. While it’s definitely more carefully associated with the marijuana market of these three, purchasing GW is not nearly as dangerous as purchasing a normal pot stock. The pharmaceutical company does not need to worry about vaping risks or criticism surrounding high tetrahydrocannabinol (THC) products such as edibles. On the other hand, it still delights in remarkable sales development.
In 2019, sales of $311 million overshadowed the prior-year’s tally of simply $15 million, mainly to do with the launch of Epidiolex in the U.S., which sent the company’s income soaring.
All 3 stocks might offer investors a good mix of diversification and development
The stocks noted above offer investors distinct methods to get exposure to marijuana without handling a lot of the dangers often associated with doing so. The companies all have strong businesses that do not look to be in any imminent risk and could be appealing buys even without factoring in cannabis.
Here’s a quick overview of how they have actually done against the S&P 500 over the past year.
While Shopify’s been by far the much better investment of the three, Couche-Tard and GW stand to get more from the marijuana industry’s development as they’re more directly involved, and that might make them underrated buys moving forward.
Eventually, it’ll depend on your choice, but these stocks are fantastic examples of methods you can invest in marijuana without taking on too much risk.
I viewed a few minutes of Nik Wallenda strolling a high-wire across an active volcano last week.
That’s type of the method I see the global cannabis industry. There have actually been some stiff headwinds. There have actually been some dicey areas. But I still believe the cannabis market will grow to be much bigger than it is right now.
2 of the top players in the marijuana market are Canopy Development( NYSE: CGC) and Scotts Miracle-Gro( NYSE: SMG) Although their service models are rather various, both business appear to have what it requires to go the distance. Which stock is the better choice for long-term investors?
Image source: Getty Images.
The case for Canopy Development
Canada boasts the biggest market in the world where cannabis is legal across the country. And Canopy Growth declares the biggest market share in that market.
Look for the Canadian market to grow considerably over the next couple of years. The Cannabis 2.0 market for marijuana derivatives products is simply beginning. Ontario, Canada’s most heavily populated province, is lastly beginning to issue more much-needed retail marijuana licenses. Canopy Growth must be among the most significant winners– and probably the biggest winner– from these advancements.
But there’s an even bigger chance in global marijuana markets. Canopy Growth is currently among the leading suppliers of medical marijuana in Germany. It likewise has operations in other European countries, consisting of Denmark and the United Kingdom, in Latin America, in southern Africa, and in Australia.
The most essential marijuana opportunity of all, however, is in the U.S. Canopy Growth can’t get in the U.S. marijuana market and keep its shares noted on significant stock market. Nevertheless, the business is poised to right away jump into the U.S. must federal cannabis laws alter thanks to its choice to acquire U.S.-based Acreage Holdings It’s also currently marketing hemp-based CBD products in the U.S., which isn’t an issue considering that hemp is legal at the federal level.
Canopy Development’s biggest competitive advantage is its relationship with Constellation Brands
What’s the most significant knock against Canopy Development?
The case for Scotts Miracle-Gro
Scotts Miracle-Gro is best understood for its customer lawn and garden items. The business made approximately 45%of its overall earnings from this business in its fiscal 2020 very first quarter.
And Scotts’ consumer lawn and garden items continue to deliver strong development.
The real development story for Scotts Miracle-Gro, however, is with its Hawthorne section, which concentrates on providing gardening products to the marijuana market. The sector’s profits leapt 41%year over year in Q1 to $1988 million.
A considerable portion of Hawthorne’s development has actually come as a result of acquisitions. The company has actually also benefited from a rebound in California’s marijuana market as well as other expanding marijuana markets in Colorado, Michigan, Illinois, and Florida.
Scotts is poised to experience a lot more growth as more states legislate either medical or leisure cannabis and as existing cannabis markets develop. The business would also be a big winner if the U.S. legalizes cannabis at the federal level.
Unlike Canopy Development, Scotts Miracle-Gro is currently consistently successful and has actually been for a very long time. The company even pays a dividend with a yield of nearly 2%.
Canopy Development could deliver the greatest gains over the long run. I think that Scotts Miracle-Gro is the much safer pick.
Cannabis stocks can be exceptionally volatile. Scotts’ solid financial position and cushion from its consumer yard and garden organisation make it less dangerous than a lot of stocks with cannabis connections, in my view. Like Nik Wallenda in his tight-wire walk throughout a volcano, Scotts Miracle-Gro has a safeguard.
Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands and Scotts Miracle-Gro. The Motley Fool has a disclosure policy.”>
Industry Leaders Join Forces to Provide Spa Consumers with Products That Harness the Power of Hemp Seed Oil & Terpenes
HUNTINGTON STATION, N.Y., March 5, 2020 /PRNewswire/ — Cannafloria Essentials, the hemp-infused wellness collection of bath, body, and aromatherapy products from prolific manufacturer Aromafloria, announces an exclusive partnership with Universal Companies as its official distributor in the spa market.
This innovative product line contains an expertly developed blend of hemp seed oil and terpenes found in Cannafloria’s proprietary THT™ (Thera Hemp Terpenes) technology, and targeted essential oil blends—a trifecta that is redefining the restorative properties of aromatherapy. This partnership will allow consumers to take part in the therapeutic experience of plant-based topicals with the helping hands of trained spa professionals.
The joint mission of this partnership is being at the forefront of the cannabis movement by letting consumers experience the mood-modulating benefits of the plant’s compounds. Two forces have come together to enable spa-goers to combine skin care and beauty within as a holistic approach to wellness. Providing these unique products to dedicated spa professionals across the country allows for the power of education and experience to shine through. This is a union meant to deliver the mission of Cannafloria Essentials to consumers who seek uplifting encounters within the spa sector.
The partnership between Cannafloria Essentials and Universal Companies derives from two female-driven legacy brands continuously breaking barriers in the wellness world. A pioneer in the cannabis beauty sector, CEO of Aromafloria Wellness Brands, Sharon K. Christie has been devoted to sharing the plant’s benefits throughout her 30-year career as a pharmacist, chemist, and aromatherapist.
Cannafloria Essentials’ brand extension into the spa market is a logical next step for the integration of cannabis in the spa industry. Consumer interest has been on the rise, with more consumers adding self-care and spa treatments into their health regimes. “My goal is to not only help consumers achieve balance and wellness, but to be a resource that helps to provide a deep understanding about the powerful synergistic effects of hemp and aromatherapy,” says Christie. “This alliance is an incredible opportunity to grow the cannabis market in the spa sector, giving consumers the chance to experience the mood-modulating benefits of my products first-hand. Neuroscience is validating that our wellness is determined by our mood.”
Founder and Chairwoman Marti Morenings leads from a place a passion, inspiration, and mindfulness. “Spas are at the front and center of the 4.5 trillion wellness economy. Our partnership with Cannafloria gives us an opportunity to reach millions of consumers who are looking to their spa practitioners for self-care advice,” says Morenings. Renowned for its commitment to providing quality product and service education for over 35 years, Universal Companies remains a trusted spa industry provider. She believes that this union among two leaders with great respect for one another and the industry, will help to spread the word about hemp seed oil and terpene benefits for overall wellness.
The Cannafloria Essentials collection is being distributed by Universal Companies to spas that wish to offer clean, cruelty-free hemp-infused sustainable beauty in their retail boutiques. The collection features seven aromas or “moods” to boost any mindset and nine formulations, including all-natural, CBD-free body lotions, bath fizzes, bath milks, sugar scrubs, aromatherapy roll-ons, and inhalation pouches. Universal Companies also plans to offer Cannafloria Hemp CBD Infused Booster Oil in the near future. This backbar product will allow spa professionals to personalize each client’s wellness experience.
For more information about Cannafloria Essentials spa distribution, please contact Universal Companies at 800.558.5571.
About Cannafloria Essentials
Cannafloria Essentials is an aromatherapy and body care line formulated with THT™ (Thera-Hemp Terpenes™), cannabis sativa seed oil, and cannabis terpenes to help consumers breathe in the moment and reconnect with the mind and body. These supercharged ingredients and essential oils satisfy any wellness craving and can be used as a convenient on-the-go aromatherapy solution providing users with a complete mood makeover that allows them to be in the now. Cannafloria’s revolutionary, ethically crafted hemp-infused products are all natural and vegan-based, cruelty-free, paraben-free, and dye-free—all manufactured in a USDA Certified Organic, 100% wind-powered facility.
About Universal Companies
For more than 36 years, 35,000+ spa professionals in 47 countries have trusted Universal Companies to be their single-source supplier, providing thousands of products to help them manage and grow their businesses. Located Abingdon, Virginia, the company distributes furniture, fixtures, equipment, implements, supplies, and spa apparel to customers from the largest spa to the independent practitioner. Universal Companies also offers professional skin and body products, retail items, and merchandising tools, and provides spas with innovative consulting services, educational materials, and training options. For more information about Universal Companies, please visit www.universalcompanies.com.
For press inquiries, please contact INK & ROSES: Aracely Gomez | [email protected] | 212.218.1484.
View original content to download multimedia: http://www.prnewswire.com/news-releases/cannafloria-essentials-partners-with-universal-companies-for-spa-distribution-301018575.html
SOURCE Cannafloria Essentials
Marijuana Company of America, and its subsidiary hempSMART™, offers important CBD information for Immune Support and Reduces the Price on our CBD Drops
ESCONDIDO, Calif., March 23, 2020 /PRNewswire/ — MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company“) (OTCQB: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that the subsidiary, hempSMART™, will offer products to consumers at a substantial savings.
In today’s climate of concern about immune system health, Paula Vetter FNP, Chairman of hempSMART’s Medical Advisory Board, pointed out that “maintaining a healthy immune system requires a multi-faceted approach. Along with common sense measures like social distancing and hand washing, we can enable our immune system to function optimally by specifically supporting our Endocannabinoid System with a quality CBD product.”
The Journal of Cannabis & Cannabinoid Research (Sept 2019) recently published findings that demonstrate that the immune system is modulated by the Endocannabinoid System (ECS). This system, which is present in humans and all other mammals, acts as the “orchestra conductor” of the body.
The ECS has three major functions:
to balance & regulate immune response & inflammation
to balance & regulate brain chemistry (neurotransmitters)
to balance & regulate hormone levels (sex hormones, adrenal hormones, thyroid hormones)
Vetter emphasized that “CBD is very popular, but many available products are not therapeutic. All CBD is NOT created equal. Our hempSMART CBD drops are organically grown, contain the full spectrum of cannabinoids, terpenes, and flavonoids (with selective removal of only THC). That means no ‘high’ or risk of failing a drug test. Most importantly, the purity, potency, and integrity of the product is verified by an independent certified laboratory. Comprehensive Certificates of Analysis, for every batch of every product, guarantee that hempSMART is a brand that you can TRUST.”
“NO CBD product specifically treats disease,” said Vetter. “A high quality, bioavailable, full spectrum CBD will powerfully support the ECS to carry out its important functions. Supporting the wisdom of the human body is the BEST defense we have against any health challenge.”
Trevor Meuhfelder, COO of hempSMART™ states, “With the limitation of services and precautionary measures being taken currently, MCOA believes that this is an opportunity to ramp up our sales of CBD products as immune system health is critical. Our products are specifically designed to help maintain a healthy endocannabinoid system which directly contributes to the functionality of the immune system.”
Global Sales and Marketing Director, Gloria Lynch, “We are now providing an online promotion for hempSMART DROPS, 250 mg tinctures which we are offering at $30.00 (regularly $45.00). We have recently seen an increase demand for our hempSMART Drops and we are happy to provide consumers with our superior products.”
Go to https://shop.hempsmart.com/#/shop/detail/FST250-LEMN/from/1271. “I am in complete agreement with Paula Vetter that in this stressful time anything we can do to strengthen our immune system will be very beneficial. It is important to support our natural ability to manage stress and to regulate & optimize our immune response to any challenge.
Everyone needs to stay safe, and follow the World Health Organization (WHO) recommendations of socially distancing ourselves and working remotely if possible.
Take the time to reconnect with loved ones, care for each other and support each other,” Jesus Quintero, MCOA, CEO.
The Company’s CEO went on to state, “MCOA is also aggressively looking and performing due diligence on various possible acquisition targets in the cannabis sector. This recent dramatic market correction in our sector and in the overall economy has introduced several opportunities to buy strategic distressed assets in the cannabis sector. As a public company, we are looking to acquire strategic assets and companies at deep discounts to benefit us and increase reported revenue. “
Please visit www.hempsmart.com for details about our product-line.
About Marijuana Company of America Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™, which targets general health and well-being; (2) an affiliate marketing and retail sales program to promote and sell its legal hemp-based consumer products containing CBD; (3) joint ventures and acquisitions of business entities engaged in the growth and sale of hemp and cannabis products in jurisdictions where cultivation is legal; and (4) the expansion of its business into ancillary areas as market opportunities in this segment mature and develop.
Legal Status of Cannabis
While legalized in California for recreational and medicinal use, cannabis remains a Schedule 1 drug under the Controlled Substances Act (21 U.S.C. § 811) and illegal under the federal law.
This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities and words such as “anticipate,” “seek,” “intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q, and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
For more information, please visit the Company’s websites at:
View original content to download multimedia: http://www.prnewswire.com/news-releases/marijuana-company-of-america-and-its-subsidiary-hempsmart-offers-important-cbd-information-for-immune-support-and-reduces-the-price-on-our-cbd-drops-301027912.html
SOURCE Marijuana Company of America, Inc.